D. Shaker

The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis.

J. A. Al Wakeel, M. Bakr, A. Donia, 2004, Transplantation proceedings.

Cyclosporine microemulsion formulation (sigmasporin microral) effect as first-line immunosuppressant on renal functions at 3 years.

J. A. Al Wakeel, A. Iman, T. Said, 2012, Transplantation proceedings.

Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.

J. A. Al Wakeel, N. Tarif, R. Dham, 2008, Transplantation proceedings.

Therapeutic equivalence and mg:mg switch ability of a generic cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients maintained on Sandimmun Neoral.

J. A. Al Wakeel, N. Tarif, R. Dham, 2008, Transplantation proceedings.

A multicenter clinical trial in the Arab world.

P. Dham, E. E. Abbas, D. Shaker, 2004, Transplantation proceedings.

The hematopoietic effect of Epotin (recombinant human erythropoietin-alpha) on maintenance hemodialysis end-stage kidney disease patients.

S. Al-Shohaib, M. Behairy, D. Shaker, 2010, Transplantation proceedings.

Establishing Therapeutic Bioequivalence of a Generic Salbutamol (Butalin) Metered Dose Inhaler to Ventolin

A. Abba, M. Riachy, M. Khan, 2008 .